AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DEXAMETHASONE SODIUM PHOSPHATE USP
7 registrations across 4 African markets— 6 active
Markets with DEXAMETHASONE SODIUM PHOSPHATE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LILIDEXA INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| LILIDEXA INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| DEXAMED EYE/EAR DROPS EYE/EAR DROPS | 🇷🇼Rwanda | LABORATORY & ALLIED LTD | active | Aug 2029 |
| DEXAMETHASONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION USP Eye Drops | 🇷🇼Rwanda | MERIT ORGANICS LTD. | active | Aug 2029 |
| DEXO Solution for injection | 🇷🇼Rwanda | KILITCH DRUGS (INDIA) LTD | active | Aug 2029 |
| DEXNEO INJECTION Injection | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Feb 2028 |
| DEXAMETHASONE 4MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2023 |
DEXAMETHASONE SODIUM PHOSPHATE USP in Africa — Regulatory Overview
DEXAMETHASONE SODIUM PHOSPHATE USP is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Rwanda, Ghana, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.